CRBP - Corbus Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CRBP is currently covered by 5 analysts with an average price target of $41.4. This is a potential upside of $131 (409.85%) from yesterday's end of day stock price of $8.12.

Corbus Pharmaceuticals's activity chart (see below) currently has 39 price targets and 51 ratings on display. The stock rating distribution of CRBP is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 24.45% with an average time for these price targets to be met of 180.1 days.

Highest price target for CRBP is $53, Lowest price target is $30, average price target is $41.4.

Most recent stock forecast was given by JEFF JONES from OPPENHEIMER on 07-Aug-2026. First documented stock forecast 15-Nov-2016.

Currently out of the existing stock ratings of CRBP, 13 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 10-May-2023

$48

$39.88 (491.13%)

$52

1 months 7 days ago
(07-Aug-2026)

5/15 (33.33%)

$37.83 (371.98%)

152

Buy Since 20-Sep-2024

$34

$25.26 (289.02%)

$44

2 months 22 days ago
(23-Jun-2026)

0/6 (0%)

$25.54 (301.89%)

Buy Since 20-Sep-2024

$30

$21.26 (243.25%)

$38

3 months 18 days ago
(27-May-2026)

0/3 (0%)

$22.18 (283.63%)

Buy Since 07-Dec-2018

$53

$44.26 (506.41%)

10 months 1 days ago
(13-Nov-2025)

2/9 (22.22%)

$41.93 (378.77%)

837

Buy Since 07-May-2025

$40

$31.26 (357.67%)

$40

10 months 25 days ago
(20-Oct-2025)

0/3 (0%)

$21.72 (118.82%)

Show more analysts

Please expand the browser size to see the chart

What is CRBP (Corbus Pharmaceuticals) average time for price targets to be met?

On average it took 180 days for the stock forecasts to be reached, with an average price target met ratio of 24.45%.

Which analyst most recently updated their price target on CRBP (Corbus Pharmaceuticals)?

Jeff Jones

Which analyst has the most public recommendations on CRBP (Corbus Pharmaceuticals)?

Jeff Jones works at OPPENHEIMER and has 5 price targets and 4 ratings on CRBP

Which analyst is the currently most bullish on CRBP (Corbus Pharmaceuticals)?

Christopher Marai with the highest potential upside of $951.29

Which analyst is the currently most reserved on CRBP (Corbus Pharmaceuticals)?

James Edwardes Jones with the lowest potential downside of -$13

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?